GEODE CAPITAL MANAGEMENT, LLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,753,838
-34.1%
762,421
+4.5%
0.00%
Q2 2023$2,662,474
+64.7%
729,445
+61.1%
0.00%
Q1 2023$1,616,381
+179497.9%
452,768
+43.4%
0.00%
Q4 2022$900
-99.9%
315,827
+5.8%
0.00%
Q3 2022$665,000
-10.4%
298,606
+0.2%
0.00%
Q2 2022$742,000
-72.3%
298,072
-45.6%
0.00%
Q1 2022$2,676,000
-54.6%
548,405
+5.2%
0.00%
-100.0%
Q4 2021$5,897,000
-32.8%
521,404
-13.4%
0.00%0.0%
Q3 2021$8,777,000
+45.9%
602,412
+16.7%
0.00%0.0%
Q2 2021$6,015,000
+1.5%
516,319
+6.2%
0.00%0.0%
Q1 2021$5,929,000
+10.1%
486,049
+12.9%
0.00%0.0%
Q4 2020$5,387,000
-8.6%
430,663
+10.0%
0.00%0.0%
Q3 2020$5,893,000
-36.3%
391,607
+3.8%
0.00%
-50.0%
Q2 2020$9,246,000
+111.2%
377,238
+22.2%
0.00%
+100.0%
Q1 2020$4,378,000
-47.6%
308,587
-41.4%
0.00%0.0%
Q4 2019$8,356,000
+370.5%
526,412
+149.8%
0.00%
Q3 2019$1,776,000
-3.7%
210,734
+2.7%
0.00%
Q2 2019$1,844,000
+63.2%
205,128
+40.3%
0.00%
Q1 2019$1,130,000
-8.1%
146,185
-44.2%
0.00%
Q4 2018$1,230,000
+17.1%
261,922
+125.7%
0.00%
Q3 2018$1,050,000
-19.3%
116,038
+5.8%
0.00%
Q2 2018$1,301,000
+30.1%
109,715
+54.0%
0.00%
Q1 2018$1,000,00071,2340.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders